March 10, 2016
FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use
The U.S. Food and Drug Administration has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States.
By Vanderbilt Health News